A shorter nine-month course of antibiotics might be just as effective in fighting multi-drug-resistant tuberculosis (MDR TB) as the current two-year standard, according to early results from an international clinical trial, per the New York Times. The trial saw a 78% success rate, compared with 81% for the two-year treatment.
Why it matters: Each year, nearly 500,000 people become sick with MDR TB, leading to about 200,000 deaths, according to the Centers for Disease Control and Prevention. A shorter medication regime would benefit the infected populace, which is centered in the developing world.
President Trump, situated between Secretary of State Rex Tillerson and Defense Secretary James Mattis during his Monday morning Cabinet meeting, said he "feels strongly" about his decision to decertify the Iran nuclear deal, stating that he's "tired of being taken advantage of."
Trump also revealed that he is not giving up on health care, stating: "Obamacare is finished, it's dead, it's gone...There is no such thing as Obamacare anymore." He added that Senate Republicans are currently working on a short-term fix to insurance markets after he "cut off the gravy train" by ending subsidies — a move that has threatened to throw the Affordable Care Act markets into chaos.
